GreenBone, the unique wood-derived bone regenerative implant for extensive bone damages in load-bearing and other skeletal segments.

AFFILIATION:   GreenBone Ortho srl, Faenza, Italy, Italy


Track: Medical & Biotech
Area: Regenerative Medicine
Tech Readiness: TRL 6

Tech Brief: GreenBone develops a patented bamboo-derived bone regenerative implant to treat severe non-load and load-bearing bone damage. International clinical study planned 2Q17. Seed round of 3.0M EURO in 2015. GreenBone presented at TEDxBinnenhof 2016 among the 10 very best ‘Ideas from Europe’ (March 31, The Hague NL).


Value Proposition: Bone damage and diseases affects millions of people worldwide. The economical impact is extremely relevant both on the healthcare system and the social costs. None of bone grafting products currently available is able to regenerate large bone defects. Even more when load-bearing bone gaps caused by high-energy impact (both civilian and military) are considered. GreenBone value proposition include faster therapy for bone regeneration of bone large defects, non-union fractures (non-load and load-bearing bones), and spinal fusion. It is important to note that the use of Greenbone will be more cost effective than any other bone grafting solution and biologics in the market.


Org Type: Early-stage Startup (Seed)
Booth Number: W514